IC2000
Sentinel Lymph Node Biopsy
Novadaq Technologies ULC, now a part of StrykerPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Sentinel Lymph Node Biopsy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TECHNETIUM TC 99M SULFUR COLLOID Novadaq Technologies ULC, now a part of Stryker | Phase 4 | BB |
Tilmanocept Memorial Health University Medical Center | Phase 4 | B |
Pudexacianinium Chloride Astellas Pharma Inc | Phase 2 | CCC |
MIDAZOLAM Jun Zhang | N/A | D |
PROPOFOL Jun Zhang | N/A | D |
View all 9 →
Same molecule, other indications
IC2000 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →